Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease

Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease

Clinical trials of novel therapeutics for Alzheimer’s Disease (AD) have consumed a significant amount of time and resources with largely negative results. Repurposing drugs already approved by the Food and Drug Administration (FDA), European Medicines Agency (EMA), or Worldwide for another indicatio...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Sergey Shityakov, Ekaterina V. Skorb, Carola Y. Förster, Thomas Dandekar
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: Frontiers Media S.A. 2021-10-01
Ráidu:Frontiers in Chemistry
Fáttát:
scaffold search
approved drugs
drug repurposing
alzheimer's disease
chemical similarity
molecular modeling
Liŋkkat:https://www.frontiersin.org/articles/10.3389/fchem.2021.736509/full

Interneahtta

https://www.frontiersin.org/articles/10.3389/fchem.2021.736509/full

Geahča maid